.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cerilliant
Citi
Harvard Business School
QuintilesIMS
Federal Trade Commission
Johnson and Johnson
Chubb
AstraZeneca
McKinsey

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090130

« Back to Dashboard
NDA 090130 describes PACLITAXEL, which is a drug marketed by Pliva Lachema, Actavis Totowa, Hospira, Accord Hlthcare, Mylan Labs Ltd, Sandoz Inc, Fresenius Kabi Oncol, Mylan, Teva Pharms, West-ward Pharms Int, and Teva Pharms Usa, and is included in twelve NDAs. It is available from eight suppliers. Additional details are available on the PACLITAXEL profile page.

The generic ingredient in PACLITAXEL is paclitaxel. There are sixty-seven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the paclitaxel profile page.

Summary for 090130

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 090130

Physiological EffectMicrotubule Inhibition

Medical Subject Heading (MeSH) Categories for 090130

Suppliers and Packaging for NDA: 090130

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PACLITAXEL
paclitaxel
INJECTABLE;INJECTION 090130 ANDA Sagent Pharmaceuticals 25021-213 25021-213-05 1 VIAL in 1 CARTON (25021-213-05) > 5 mL in 1 VIAL
PACLITAXEL
paclitaxel
INJECTABLE;INJECTION 090130 ANDA Sagent Pharmaceuticals 25021-213 25021-213-17 1 VIAL in 1 CARTON (25021-213-17) > 16.7 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength6MG/ML
Approval Date:Dec 9, 2009TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Medtronic
UBS
Covington
QuintilesIMS
Johnson and Johnson
Fish and Richardson
Cerilliant
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot